LUNG ADENOCARCINOMA STAGE III

LUNG ADENOCARCINOMA STAGE III was reported 87 times

These drug classes are most commonly taken by patients reporting LUNG ADENOCARCINOMA STAGE III:

# Drug Count
0 Folate Analog Metabolic Inhibitor [EPC] 16
1 Corticosteroid [EPC] 13
2 Kinase Inhibitor [EPC] 11
3 Nonsteroidal Anti-inflammatory Drug [EPC] 9
4 Thalidomide Analog [EPC] 8
5 Tumor Necrosis Factor Blocker [EPC] 8
6 Platinum-based Drug [EPC] 7
7 Provitamin D2 Compound [EPC] 7
8 Benzodiazepine [EPC] 6
9 Programmed Death Receptor-1 Blocking Antibody [EPC] 6
10 Vitamin B12 [EPC] 6
11 Antirheumatic Agent [EPC] 5
12 Interleukin-23 Antagonist [EPC] 5
13 Selective T Cell Costimulation Modulator [EPC] 5
14 Vitamin C [EPC] 5
15 Vitamin D [EPC] 5
16 Aminosalicylate [EPC] 4
17 HMG-CoA Reductase Inhibitor [EPC] 4
18 Microtubule Inhibitor [EPC] 4
19 Platelet Aggregation Inhibitor [EPC] 4
20 5-alpha Reductase Inhibitor [EPC] 3
21 Fluoroquinolone Antibacterial [EPC] 3
22 Integrin Receptor Antagonist [EPC] 3
23 Interleukin-12 Antagonist [EPC] 3
24 Loop Diuretic [EPC] 3
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
26 alpha-Adrenergic Blocker [EPC] 3
27 beta-Adrenergic Blocker [EPC] 3
28 Angiotensin 2 Receptor Blocker [EPC] 2
29 Azole Antifungal [EPC] 2
30 CD20-directed Cytolytic Antibody [EPC] 2
31 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
32 Estrogen [EPC] 2
33 Factor Xa Inhibitor [EPC] 2
34 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
35 Leukocyte Growth Factor [EPC] 2
36 P2Y12 Platelet Inhibitor [EPC] 2
37 Phosphodiesterase 3 Inhibitor [EPC] 2
38 Proton Pump Inhibitor [EPC] 2
39 Serotonin-3 Receptor Antagonist [EPC] 2
40 Sulfonamide Antimicrobial [EPC] 2
41 Acetylcholine Release Inhibitor [EPC] 1
42 Aldosterone Antagonist [EPC] 1
43 Aluminum Complex [EPC] 1
44 Amide Local Anesthetic [EPC] 1
45 Androgen [EPC] 1
46 Angiotensin Converting Enzyme Inhibitor [EPC] 1
47 Antiarrhythmic [EPC] 1
48 Antidote [EPC] 1
49 Antidote for Acetaminophen Overdose [EPC] 1
50 Antimetabolite Immunosuppressant [EPC] 1
51 BCL-2 Inhibitor [EPC] 1
52 Calcineurin Inhibitor Immunosuppressant [EPC] 1
53 Calcium Channel Blocker [EPC] 1
54 Calcium [EPC] 1
55 Cardiac Glycoside [EPC] 1
56 Dietary Cholesterol Absorption Inhibitor [EPC] 1
57 Dihydropyridine Calcium Channel Blocker [EPC] 1
58 Endothelin Receptor Antagonist [EPC] 1
59 Ester Local Anesthetic [EPC] 1
60 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
61 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
62 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
63 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
64 Insulin Analog [EPC] 1
65 Interferon beta [EPC] 1
66 Interleukin-17A Antagonist [EPC] 1
67 Interleukin-2 Receptor Blocking Antibody [EPC] 1
68 Interleukin-4 Receptor alpha Antagonist [EPC] 1
69 Interleukin-6 Receptor Antagonist [EPC] 1
70 Mucolytic [EPC] 1
71 Neuromuscular Blocker [EPC] 1
72 Non-Standardized Chemical Allergen [EPC] 1
73 Non-narcotic Antitussive [EPC] 1
74 Osmotic Laxative [EPC] 1
75 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
76 Phosphodiesterase 4 Inhibitor [EPC] 1
77 Potassium Channel Blocker [EPC] 1
78 Pyrimidine Synthesis Inhibitor [EPC] 1
79 Serotonin Reuptake Inhibitor [EPC] 1
80 Tetracycline-class Drug [EPC] 1
81 Topoisomerase Inhibitor [EPC] 1
82 Xanthine Oxidase Inhibitor [EPC] 1